David C Hohn insider trades: Cleveland Biolabs (CBLI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 2, 2012 | CBLI | ↑ Buy | 1,000 | $1.61 | $2K | Direct | Jul 5, 2012 (3d) |
| Apr 4, 2012 | CBLI | ↑ Buy | 1,000 | $1.71 | $2K | Direct | Apr 6, 2012 (2d) |
| Jan 4, 2012 | CBLI | ↑ Buy | 1,000 | $2.98 | $3K | Direct | Jan 5, 2012 (1d) |
| Oct 4, 2011 | CBLI | ↑ Buy | 1,000 | $2.36 | $2K | Direct | Oct 6, 2011 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David C Hohn's insider trades
David C Hohn is a director at Cleveland Biolabs (CBLI). Since Oct 4, 2011, David has reported 4 open-market purchases worth $9K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CBLI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.